Accéder au contenu
Merck

Regulation of Osteoclast Differentiation by Myosin X.

Scientific reports (2017-08-10)
Amy Tasca, Kristina Astleford, Ari Lederman, Eric D Jensen, Beth S Lee, Rajaram Gopalakrishnan, Kim C Mansky
RÉSUMÉ

Osteoclasts begin as mononuclear cells that fuse to form multinuclear cells able to resorb bone. The mechanisms that regulate all the steps of osteoclast differentiation are not entirely known. MYO10, an unconventional myosin, has previously been shown in mature osteoclasts to play a role in attachment and podosome positioning. We determined that MYO10 is also expressed early during osteoclast differentiation. Loss of MYO10 expression in osteoclast precursors inhibits the ability of mononuclear osteoclasts to fuse into multinuclear osteoclasts. Expression of Nfatc1, Dc-stamp, Ctsk, and β

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-MYO10 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution